Could a daily dose of citrus fiber tame fatty liver inflammation?

NCT ID NCT07093346

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This trial tests whether a daily supplement of pectin — a fiber found in citrus peels — can reduce inflammation and improve gut bacteria in adults with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), a common form of fatty liver. For six weeks, participants take either pectin mixed with cocoa powder or a placebo (cocoa powder alone). Researchers measure changes in blood markers of inflammation, gut microbiome composition, and metabolic health indicators like BMI and blood sugar.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a dietary supplement called pectin, a fiber from citrus peels, taken daily for 6 weeks
What this could lead to
If pectin reduces inflammation and improves gut bacteria, it could point toward a simple dietary approach to help manage fatty liver disease.
What could go wrong
This is a small, early-stage trial with only 45 participants. Pectin is a common food ingredient, so major risks are low, but its effects on liver inflammation are unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MASLD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Nottingham Clinical Research Facility at Nottingham University Hospitals NHS Trust

    RECRUITING

    Nottingham, NG7 2UH, United Kingdom

  • Sir Peter Mansfield Imaging Centre, University of Nottingham

    RECRUITING

    Nottingham, NG7 2QX, United Kingdom

  • University of Nottingham

    RECRUITING

    Nottingham, United Kingdom, NG7 2UH, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.